Alkaline phosphatase band-10 fraction as a possible surrogate marker for human immunodeficiency virus type 1

V V Murthy1, T A Calvelli, A Rubinstein

  • 1Department of Laboratory Medicine, Albert Einstein College of Medicine, Bronx, NY 10461.

Insights

Alkaline phosphatase band 10 (ALP band-10) in serum effectively predicts human immunodeficiency virus type 1 (HIV-1) infection in infants. This early HIV-1 detection marker aids in identifying infected children born to HIV-1-positive mothers.

Area of Science:

  • Biochemistry
  • Immunology
  • Pediatrics

Background:

  • Early diagnosis of human immunodeficiency virus type 1 (HIV-1) infection in infants is crucial for timely intervention.
  • Current diagnostic methods may have limitations in early detection, especially before maternal antibody clearance.

Purpose of the Study:

  • To evaluate the utility of serum alkaline phosphatase band 10 (ALP band-10) activity as a predictive marker for HIV-1 infection in children.
  • To assess the correlation of ALP band-10 with confirmed HIV-1 infection status in infants born to HIV-1-seropositive mothers.

Main Methods:

  • Serum samples from infants born to HIV-1-seropositive mothers were analyzed for ALP band-10 activity.
  • HIV-1 infection status was determined through HIV-1 culture, p24 antigen testing, and maternal antibody clearance confirmation.
  • ALP band-10 activity was correlated with established HIV-1 infection markers.

Main Results:

  • Serum ALP band-10 activity consistently correlated with confirmed HIV-1 infection status.
  • ALP band-10 correctly identified HIV-1 infection in 31 samples from 18 pediatric patients.
  • No ALP band-10 activity was detected in 14 control samples from uninfected infants.

Conclusions:

  • Serum ALP band-10 activity serves as a reliable surrogate marker for early HIV-1 infection detection in infants.
  • This marker can facilitate early identification of HIV-1 in infants born to seropositive mothers, even before maternal antibody clearance.
  • The utility of ALP band-10 in children as young as two months highlights its potential for timely pediatric HIV-1 management.

Related Concept Videos